Pursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the medicine set out in the Schedule hereto:
|Active Ingredient:||Riluzole 50mg|
|Dosage Form:||Film coated tablet|
|New Zealand Sponsor:||Sanofi-Aventis New Zealand Limited|
|Manufacturer:||Sanofi Winthrop Industrie, Compiegne, France|
Note: This consent is given subject to the following conditions:
Also note: This renewed consent is valid for two years from 11 November 2019.
Dated this 25th day of October 2019.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).